Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits

NCT03616496 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Amyloidosis

Interventions

DRUG: Neuraceq PET/CT imaging

Sponsor

Central Hospital, Nancy, France